RNA Vaccine Regulatory Workshop

On 28 and 29 July 2026, 17 national regulatory authorities from across Latin America and the Carribean came together to work through the regulatory pathways that guide RNA vaccines from the laboratory to public health. The aim was to build reviewer fluency in RNA-vaccine science and to promote regulatory convergence — from the technical basis of the platform through emergency development, reliance, and RNA-specific GMP inspection.
The workshop report and presentation slides are now available:

Full Report ENGLISH Full Report SPANISH Day 1 SlidesDay 2 Slides

Responsive Table

VMFN Partner WHO LMIC Region Modality Status at each VMFN Partner
mRNA rProtein Viral Vector
Aspen (drug product f/f only) Africa      
IPD      
Serum Institute of India SE Asia      
BioFarma      
Fiocruz-BioManguinhos LAC      
Samsung Biologics W Pacific      

Key

Developed Developing To be developed